Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021;13(4):70-80.
doi: 10.17691/stm2021.13.4.08. Epub 2021 Aug 28.

Proton Therapy in Head and Neck Cancer Treatment: State of the Problem and Development Prospects (Review)

Affiliations
Review

Proton Therapy in Head and Neck Cancer Treatment: State of the Problem and Development Prospects (Review)

K B Gordon et al. Sovrem Tekhnologii Med. 2021.

Abstract

Proton therapy (PT) due to dosimetric characteristics (Bragg peak formation, sharp dose slowdown) is currently one of the most high-tech techniques of radiation therapy exceeding the standards of photon methods. In recent decades, PT has traditionally been used, primarily, for head and neck cancers (HNC) including skull base tumors. Regardless of the fact that recently PT application area has significantly expanded, HNC still remain a leading indication for proton radiation since PT's physic-dosimetric and radiobiological advantages enable to achieve the best treatment results in these tumors. The present review is devoted to PT usage in HNC treatment in the world and Russian medicine, the prospects for further technique development, the assessment of PT's radiobiological features, a physical and dosimetric comparison of protons photons distribution. The paper shows PT's capabilities in the treatment of skull base tumors, HNC (nasal cavity, paranasal sinuses, nasopharynx, oropharynx, and laryngopharynx, etc.), eye tumors, sialomas. The authors analyze the studies on repeated radiation and provide recent experimental data on favorable profile of proton radiation compared to the conventional radiation therapy. The review enables to conclude that currently PT is a dynamic radiation technique opening up new opportunities for improving therapy of oncology patients, especially those with HNC.

Keywords: head and neck cancer; proton therapy; reirradiation therapy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest. The authors declare no conflicts of interest related to the present study.

Similar articles

Cited by

References

    1. Kaprin A.D., Starinskiy V.V., Petrova G.V., editors. Sostoyanie onkologicheskoy pomoshchi naseleniyu rossii v 2018 godu. Moscow: MNIOI im. P.A. Gertsena — filial FGBU “NMIRTs” Minzdrava Rossii; 2019. p. 236. [The state of oncological care for the population of Russia in 2018].
    1. Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi: 10.3322/caac.21590. - DOI - PubMed
    1. Nutting C.M., Morden J.P., Harrington K.J., Urbano T.G., Bhide S.A., Clark C., Miles E.A., Miah A.B., Newbold K., Tanay M., Adab F., Jefferies S.J., Scrase C., Yap B.K., A’Hern R.P., Sydenham M.A., Emson M., Hall E. PARSPORT trial management group. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomized controlled trial. Lancet Oncol. 2011;12(2):127–136. doi: 10.1016/s1470-2045(10)70290-4. - DOI - PMC - PubMed
    1. Peng G., Wang T., Yang K.Y., Zhang S., Zhang T., Li Q., Han J., Wu G. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol. 2012;104(3):286–293. doi: 10.1016/j.radonc.2012.08.013. - DOI - PubMed
    1. Rosenthal D.I., Chambers M.S., Fuller C.D., Rebueno N.C., Garcia J., Kies M.S., Morrison W.H., Ang K.K., Garden A.S. Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 2008;72(3):747–755. doi: 10.1016/j.ijrobp.2008.01.012. - DOI - PMC - PubMed

LinkOut - more resources